Phytomedicine
Volume 10 , Pages 25-30 , 2003

Treating depression comorbid with anxiety – results of an open, practice-oriented study with St John's wort WS® 5572 and valerian extract in high doses

References 

  1. Bruce SE , Machan JT , Dyck I , Keller MB . Infrequency of “pure” GAD: impact of psychiatric comorbidity on clinical course . Depress Anxiety . 2001;14:219–225
  2. Dominguez RA , Bravo-Valverde RL , Kaplowitz BR , Cott JM . Valerian as a hypnotic for Hispanic patients . Cultur Divers Ethni Minor Psychol . 2000;6:84–92
  3. Donath F , Quispe S , Diefenbach K , Maurer A , Fietze I , Roots I . Critical evaluation of the effect of valerian extract on sleep structure and sleep quality . Pharmacopsychiatry . 2000;33:47–53
  4. Dorn M . Efficacy and tolerability of Baldrian versus oxazepam in non-organic and non-psychiatric insomniacs: a randomised, double-blind, clinical, comparative study . Forsch Komplementärmed Klass Naturheilkd . 2000;7:79–84
  5. Kasper S . Hypericum perforatum — a review of clinical studies . Pharmacopsychiatry . 2001;34(Suppl 1):51–55
  6. Katz DA , McHorney CA . The relationship between insomnia and health-related quality of life in patients with chronic illness . J Fam Pract . 2002;51:229–235
  7. Laakmann G , Schule C , Baghai T , Kieser M . St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy . Pharmacopsychiatry . 1998;31(Suppl 1):54–59
  8. Le Pine JP , Gastpar M , Mendlewicz J , Tylee A . Depression in the community: the first Pan-European study DEPRES . Int Clin Psychopharmacol . 1997;12:19–29
  9. Leathwood PD , Chauffard F , Heck E , Munoz-Box R . Aqueous extract of valerian root (Valeriana officinalis L.) improves sleep quality in man . Pharmacol Biochem Behav . 1982;17:65–67
  10. Lecrubier Y . The burden of depression and anxiety in general medicine . J Clin Psychiatry . 2001;62(Suppl 8):4–9
  11. Lim D , Sanderson K , Andrews G . Lost productivity among full-time workers with mental disorders . J Ment Health Policy Econ . 2000;3:139–146
  12. Malhi GS , Parker GB , Gladstone G , Wilhelm K , Mitchell PB . Recognizing the anxious face of depression . J Nerv Ment Dis . 2002;190:366–373
  13. Melartin TK , Rytsala HJ , Leskela US , Lestela-Mielonen PS , Sokero TP , Isometsa ET . Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study . J Clin Psychiatry . 2002;63:126–134
  14. Rychlik R , Siedentop H , von den Driesch V , Kasper S . Johanniskrautextrakt WS® 5572 bei leichten bis mittelschweren Depressionen . MMW Fortschr Med . 2001;119:119–128
  15. Sartorius N , Ustun TB , Lecrubier Y , Wittchen HU . Depression comorbid with anxiety: results from the WHO study on psychological disorders in primary health care . Brit J Psychiatry . 1996;30(Suppl 1):38–43
  16. Schulz H , Stolz C , Muller J . The effect of valerian extract on sleep polygraphy in poor sleepers: a pilot study . Pharmacopsychiatry . 1994;27:147–151
  17. Spalletta G , Pasini A , Caltagirone C . Fluoxetine alone in the treatment of first episode anxious-depression: an open clinical trial . J Clin Psychopharmacol . 2002;22:263–266
  18. Sramek JJ , Zarotsky V , Cutler NR . Generalised anxiety disorder: treatment options . Drugs . 2002;62:1635–1648
  19. Volz HP , Laux P . Antidepressive Pharmakotherapie leichter bis mittelgradiger depressiver Störungen . Psychopharmakotherapie . 1999;6:138–142
  20. Wagstaff AJ , Cheer SM , Matheson AJ , Ormrod D , Goa KL . Spotlight on paroxetine in psychiatric disorders in adults . CNS Drugs . 2002;16:425–434
  21. Wheatley D . Kava and valerian in the treatment of stress-induced insomnia . Phytother Res . 2001;15:549–551
  22. Wittchen HU , Kessler RC , Beesdo K , Krause P , Hofler M , Hoyer J . Generalized anxiety and depression in primary care: prevalence, recognition, and management . J Clin Psychiatry . 2002;63(Suppl 8):24–34

PII: S0944-7113(04)70348-7

doi: 10.1078/1433-187X-00305

Phytomedicine
Volume 10 , Pages 25-30 , 2003

Article Tools